Predicting the Effectiveness of 2 Chemotherapy Regimens Applied to Breast Cancer Patients by Nutritional and Inflammatory Status.

Med Sci Monit · 2026 · PMC12837116 · PMID 41572592

Europe PMC DOI

hedged sentences

0.0620

closest p · 1.2× alpha

0.0650

boldest claim

The sentences

borderline non-significantP =0.062so close (0.05 < p ≤ 0.1)

Similarly, when evaluating the interval between NAC and surgery, survival analyses yielded a mean survival time of 7.04 months (95% CI: 3.68–10.40) for the ddAC-THP group and 11.58 months (95% CI: 8.09–15.07) for the TCHP, with borderline non-significant results (log-rank test; P =0.062).

also in 434 other papers

did not reach statistical significanceP =0.065so close (0.05 < p ≤ 0.1)

There was a trend toward better survival with TCHP, but it did not reach statistical significance (log-rank P =0.065).

also in 111,027 other papers

of borderline significanceno p-value reported

However, the survival difference was only of borderline significance in time-to-event analysis.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.